Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis.
- Resource Type
- Article
- Source
- Drug Design, Development & Therapy; Sep2022, Vol. 16, p3071-3085, 15p
- Subject
- Language
- ISSN
- 11778881